Course Description
Hematologists/oncologists and their teams of NPs, PAs, oncology nurses, and pharmacists caring for patients with MM
Are you prepared for the next wave of innovation in relapsed/refractory multiple myeloma (MM)? How familiar are you with the science behind GPRC5D and the emerging therapies targeting this novel antigen?
Through this interactive Booster Quiz, test your knowledge and clinical insight on the rationale for targeting GPRC5D, the unmet needs it addresses in MM, and the latest clinical data on investigational GPRC5D-directed T-cell therapies.
What You’ll Learn From This Course
- This unique learning experience provides:
- Instant expert feedback on your answer selections
- An opportunity to see how well you do relative to your peers
- A downloadable summary with key supporting evidence and relevant practice tips.
Lessons:
